Tocilizumab (Actemra) scores FDA approval for systemic sclerosis–associated interstitial lung diseaseMarch 5, 2021Lupus & Connective Tissue Diseases
ACR, AAD, AAO, RDS issue joint statement on safe use of hydroxychloroquineMarch 2, 2021Lupus & Connective Tissue DiseasesRheumatoid ArthritisPediatrics
COVID-19 vaccination recommended for rheumatology patientsFebruary 24, 2021COVID-19 UpdatesAnkylosing spondylitisGoutLupus & Connective Tissue DiseasesOsteoarthritisOsteoporosisPediatrics
Frozen sections can guide biopsies for giant cell arteritis, but are they feasible?February 23, 2021Lupus & Connective Tissue Diseases
Outcomes have improved for PAH in connective tissue diseaseFebruary 17, 2021Lupus & Connective Tissue Diseases
Consider home subcutaneous immune globulin for refractory dermatomyositisFebruary 17, 2021Lupus & Connective Tissue Diseases
Tocilizumab may improve lung function in early systemic sclerosisFebruary 17, 2021Lupus & Connective Tissue Diseases
Checkpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseasesFebruary 16, 2021Rheumatoid ArthritisLupus & Connective Tissue Diseases
Women increasingly turn to CBD, with or without doc’s blessingFebruary 10, 2021Lupus & Connective Tissue DiseasesPain
Rheumatologic disease activity an important influencer of COVID-19 death riskFebruary 5, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesGoutAnkylosing spondylitis
Palliative care underused in pulmonary arterial hypertensionJanuary 26, 2021Lupus & Connective Tissue Diseases
Severe renal arteriosclerosis may indicate cardiovascular risk in lupus nephritisJanuary 22, 2021Lupus & Connective Tissue Diseases
Treprostinil offers some benefits for patients with ILD-associated pulmonary hypertensionJanuary 13, 2021Lupus & Connective Tissue Diseases
